Literature DB >> 27429491

Accuracy of point-of-care testing for circulatory cathodic antigen in the detection of schistosome infection: systematic review and meta-analysis.

Anthony Danso-Appiah1, Jonathan Minton2, Daniel Boamah3, Joseph Otchere4, Richard H Asmah5, Mark Rodgers6, Kwabena M Bosompem4, Paolo Eusebi7, Sake J De Vlas8.   

Abstract

OBJECTIVE: To assess the accuracy of point-of-care testing for circulatory cathodic antigen in the diagnosis of schistosome infection.
METHODS: We searched MEDLINE, EMBASE, LILACS and other bibliographic databases for studies published until 30 September 2015 that described circulatory cathodic antigen testing compared against one to three Kato-Katz tests per subject - for Schistosoma mansoni - or the filtration of one 10-ml urine sample per subject - for S. haematobium. We extracted the numbers of true positives, false positives, true negatives and false negatives for the antigen testing and performed meta-analyses using a bivariate hierarchical regression model.
FINDINGS: Twenty-six studies published between 1994 and 2014 met the inclusion criteria. In the detection of S. mansoni, a single antigen test gave a pooled sensitivity of 0.90 (95% confidence interval, CI: 0.84-0.94) and a pooled specificity of 0.56 (95% CI: 0.39-0.71; n = 7) when compared against a single Kato-Katz test. The corresponding values from comparisons with two to three Kato-Katz tests per subject were 0.85 (95% CI: 0.80-0.88) and 0.66 (95% CI: 0.53-0.76; n = 14), respectively. There appeared to be no advantage in using three antigen tests per subject instead of one. When compared against the results of urine filtration, antigen testing for S. haematobium showed poor sensitivity and poor specificity. The performance of antigen testing was better in areas of high endemicity than in settings with low endemicity.
CONCLUSION: Antigen testing may represent an effective tool for monitoring programmes for the control of S. mansoni.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27429491      PMCID: PMC4933137          DOI: 10.2471/BLT.15.158741

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


Introduction

Schistosomiasis is common in low-income tropical and subtropical countries, especially where it is difficult to provide basic care at the peripheral level. Almost a billion people are estimated to be at risk of schistosome infection and over 200 million are infected.– As there is a high risk of reinfection after treatment, repeated screening and treatment are important., Schistosoma mansoni and S. japonicum cause most cases of intestinal schistosomiasis while S. haematobium causes urogenital schistosomiasis. Although the World Health Organization’s (WHO’s) strategy for schistosomiasis control was largely based on active case detection and treatment with praziquantel, mass treatment – with no prior diagnosis – is now increasingly employed in areas with high endemicity. Most diagnosis is based on Kato–Katz thick smears for intestinal schistosomiasis and urine filtration for urogenital schistosomiasis. The sensitivity of both of these diagnostic techniques depends on the severity of infection and often falls below 30% for mild infections., Although repeated sampling – e.g. the taking of several stool specimens on different days, from each subject, for Kato–Katz testing – can increase sensitivity, it also increases costs and the risk of false-positive results. Since the introduction of mass drug administration within the preventive chemotherapy strategy, the prevalence and intensity of schistosome infection has fallen substantially in most settings and, in consequence, such infection has become harder to detect. Better but low-cost diagnostic tests are now needed to increase sensitivity without compromising specificity. It is possible to detect some schistosome infections by testing for either of two of the parasites’ secretory metabolites that have been linked with active infection: circulatory anodic antigen and circulatory cathodic antigen.– A cassette assay for the point-of-care testing of urine samples for the latter antigen has been developed. When validated in settings in Africa, this assay was generally found to be much more sensitive – in the detection of S. mansoni infection – than the Kato–Katz test, although it appeared to suffer the same limitation when intensities of infection were low.– Systematic reviews are widely regarded as providing the best evidence to inform health-care decisions., The systematic review and meta-analysis described below was commissioned by WHO to assess the diagnostic accuracy of point-of-care testing for circulatory cathodic antigen – hereafter called antigen testing. A Cochrane review was recently published on the same topic. The main aim of the review and meta-analysis was to evaluate the accuracy of antigen testing in the detection of all schistosome infections. We generally used the examination of two Kato–Katz thick smears of stools per subject as the reference standard in the detection of S. mansoni and S. japonicum and the filtration of 10 ml of urine per subject as the corresponding standard for S. haematobium.

Methods

Search methods

We searched MEDLINE, EMBASE and LILACS for relevant articles, in any language, recorded between the inception of each database and 30 September 2015. We also searched BIOSIS, Web of Science, Google Scholar, the Rapid Medical Diagnostics database, African Journals Online, Cochrane Infectious Diseases Group Specialized Register, the Cochrane Library 2015 and the metaRegister of Controlled Trials. We maximized the sensitivity of our search by using free texts based on the index test and target condition – i.e. antigen testing and schistosome infection, respectively. We also hand-checked the reference lists of relevant articles and textbooks and contacted experts in the field to see if they had any relevant but unpublished data.

Inclusion criteria

We considered a study for inclusion if, for the detection of schistosome infection, it compared antigen testing with Kato–Katz tests and/or urine filtration, the pre-control infection status of the participants was not known, the same participants were checked using antigen tests and at least one reference test, and data on diagnostic accuracy were reported. The data included in our review had to come from study participants whose stools had been checked for S. mansoni and/or S. japonicum eggs using the Kato–Katz test or whose urine had been checked for S. haematobium eggs using filtration of a 10 ml sample and microscopical examination of the filter.

Diagnostic thresholds

Stool samples found to contain fewer than 100, 100–399 and more than 399 eggs per gram of faeces when examined as Kato–Katz smears were considered to come from participants with light, moderate and heavy infections, respectively. Urine that contained fewer than 51 or more than 50 eggs per 10-ml sample was considered to come from participants with light and heavy infections, respectively. All of the included results of antigen testing had been classifying qualitatively as: trace as negative, trace as positive or single, double or triple positive.

Study selection

One author conducted the initial wide-ranging search of the literature. Two other authors then screened the results to identify those studies that were potentially relevant and useful. Full study reports were then obtained and checked to see if they satisfied several predefined inclusion criteria. Any discrepancies were resolved through discussion between the authors.

Data extraction and management

Using a standardized form, two authors extracted study characteristics such as the country and year in which the study was conducted and the study design and the methods. Information on diagnostic criteria – e.g. the number of stool and urine samples examined per participant and the diagnostic thresholds employed – and epidemiological and demographic data – e.g. endemicity status, region where the study was conducted, participants’ prior treatment status, target population, sex, age and number of participants and whether diagnosis was delivered at the point of care – were also extracted. We extracted the numbers of true positives, false positives, true negatives and false negatives for the antigen testing – using the results of a reference test as the gold standard. When necessary, we contacted the authors of the published articles on included studies to see if they could clarify or supplement the published results or provide raw data that we could use. If two or more communities were involved in a study, data were extracted for each community – with a link to the parent study.

Data synthesis

Data were analysed and presented as sensitivities, specificities and false-positive rates, with their 95% confidence intervals (CIs). The meta-analyses were performed using the bivariate model specified by Reitsma et al. and the mada package in the R programming environment (R Foundation, Vienna, Austria). The model we used is equivalent to the hierarchical regression approach described by Rutter and Gatsonis., In the model, variance components are estimated by restricted maximum likelihood. To remove the need to adjust for confounders, we restricted our analyses to data from studies in which both index and reference standard tests were evaluated in the same participants. Subgroup effects were investigated by stratifying the analyses by age – categorized as preschool children and infants, school-aged children or adults – as well as the sensitivity of the reference standard and the background endemicity of either the intestinal schistosomiasis investigated – categorized as low, moderate or high – or the urinary schistosomiasis investigated – categorized as low or high.

Heterogeneity and subgroup analysis

We assessed heterogeneity by inspecting forest plots for overlapping confidence intervals and outlying data. Although we generally considered a P-value below 0.05 to indicate statistical significance, we used a more sensitive threshold, – i.e. a P-value below 0.10 – to indicate statistically significant heterogeneity. Where such significant heterogeneity was detected, we carried out subgroup analyses based on clinical and methodological differences. We applied an exploratory analysis based on a latent class bivariate model to investigate the performance of antigen testing – compared with Kato–Katz tests used as the reference standard. For this analysis, Latent GOLD version 5.0 (Statistical Innovations Inc., Belmont, United States of America) was used to capture the between-study heterogeneity in sensitivity and specificity – assuming that our included studies belonged to one of several latent classes.

Results

We retrieved 4578 records in the initial search. The data in 20 published articles on the 26 studies that met all of our inclusion criteria were included in the review (Fig. 1 and Table 1). In this article we present our main findings on the performance of antigen testing compared with Kato–Katz smears and urine filtration. More details on this topic and on other parts of the meta-analysis we conducted are available from the corresponding author.
Fig. 1

Selection of studies included in the systematic review and meta-analysis on the accuracy of point-of-care testing for circulatory cathodic antigen in the detection of schistosome infection

Table 1

Characteristics of the studies included in the systematic review and meta-analysis on the accuracy of point-of-care testing for circulatory cathodic antigen in the detection of schistosome infection

StudyCountryYearNo. of study communitiesInitial sample sizeParticipantsAges (years)Prevalence (%)aCCA test investigated, and no. of samples per participantNo. of stool samples per participantb
Kremsner, 199417CameroonNR1148Schoolchildren4–13NREIA (1)1
De Clercq, 199736MaliNR2NRcAdults and childrenNR99.0ELISA (1)2
De Clercq, 199737Mali19934NRdAdults and childrenNRNRELISA (1)1
Legesse, 200738Ethiopia20071251Adults and children> 590.0 (schoolchildren)Reagent strip (1)1
Ayele, 200839EthiopiaNR1206Schoolchildren4–2147.6Reagent strip (1)NA
Legesse, 200840Ethiopia20071184Schoolchildren5–2236.4Reagent strip (1)1
Midzi, 200941Zimbabwe20061265Preschool children and schoolchildren2–1940.4Reagent strip (1)1
Stothard, 200942Uganda20091242Infants and preschool children< 6> 50.0Reagent strip (1)2
Sousa-Figueiredo, 201043Uganda2007 and 2009NR608Preschool children and mothers< 7e16.0 and 43.3 (children), 29.2 and 60.0 (mothers) from either Lake Victoria or Lake AlbertCassette (1)2
Standley, 201044Kenya, United Republic of Tanzania200911171Schoolchildren6–1768.6Reagent strip (1)1
Coulibaly, 201120 (study 1)fCôte d’Ivoire20101146Children8–1232.9Cassette (1, 2 or 3)1, 2 or 3
Coulibaly, 201120 (study 2)fCôte d’Ivoire20101130Children8–1253.1Cassette (1, 2 or 3)1, 2 or 3
Coulibaly, 201120 (study 3)fCôte d’Ivoire20101170Children8–1291.8Cassette (1, 2 or 3)1, 2 or 3
Shane, 201145Kenya20071484Children1–1538.8Dipstick (1)3
Tchuem Tchuenté, 201221 (study 1)fCameroon2010/20111765Schoolchildren8–1221.0Cassette (1) and dipstick (NR)3
Tchuem Tchuenté, 201221 (study 2)fCameroon2010/20111765Schoolchildren8–1241.8Cassette (1) and dipstick (NR)3
Tchuem Tchuenté, 201221 (study 3)fCameroon2010/20111765Schoolchildren8–1231.4Cassette (1) and dipstick (NR)3
Colley, 201322Cameroon, Côte d’Ivoire, Ethiopia, Kenya, Uganda201054305Schoolchildren9–1215.1 (Kenya), 25.0 (Uganda), 38.4 (Cameroon), 43.0 (Ethiopia) and 47.9 (Côte d’Ivoire)Cassette (1)1
Coulibaly, 201346Côte d’Ivoire20112242Preschool children< 623.1Cassette (2)2
Dawson, 201347Uganda2011NR82Preschool children< 645.0Cassette (1)2
Erko, 201348Ethiopia2010/20112620Schoolchildren8–1234.0Cassette (1, 2 or 3)1, 2 or 3
Koukounari, 201349Uganda20051446Children and adults7–16 and 17–76NRCassette (1)3
Sousa-Figueiredo, 201323 (study 1) fUganda2009NR333Preschool children< 77.2Dipstick (1)1
Sousa-Figueiredo, 201323 (study 2) fUganda2009NR337Preschool children< 716.9Dipstick (1)1
Sousa-Figueiredo, 201323 (study 3) fUganda2009NR255Preschool children< 738.8Dipstick (1)1
Adriko, 201424UgandaNR5500Schoolchildren7–138.0, 23.0 and 36.0 from low, moderate and high endemic areas, respectivelyCassette (1)1, 2 or 3

CCA: circulatory cathodic antigen; EIA: enzyme immunoassay; ELISA: enzyme-linked immunosorbent assay; NA: not applicable; NR: not reported.

a Of infection with the schistosome species of interest, as indicated by the results of the reference test.

b Each examined as a duplicate Kato–Katz smear.

c Overall, 352 serum, 134 stool and 337 urine samples were investigated

d Overall, 348 blood, 324 stool and 431 urine samples were investigated.

e Reported age of children.

f The article was conducted in settings of low, moderate and high endemicity. We treated the publication as a report on three studies, which we designated studies 1, 2 and 3.

Selection of studies included in the systematic review and meta-analysis on the accuracy of point-of-care testing for circulatory cathodic antigen in the detection of schistosome infection Note: Some reported articles were conducted in settings of low, moderate and high endemicity. We treated each of these articles as a report on three studies. CCA: circulatory cathodic antigen; EIA: enzyme immunoassay; ELISA: enzyme-linked immunosorbent assay; NA: not applicable; NR: not reported. a Of infection with the schistosome species of interest, as indicated by the results of the reference test. b Each examined as a duplicate Kato–Katz smear. c Overall, 352 serum, 134 stool and 337 urine samples were investigated d Overall, 348 blood, 324 stool and 431 urine samples were investigated. e Reported age of children. f The article was conducted in settings of low, moderate and high endemicity. We treated the publication as a report on three studies, which we designated studies 1, 2 and 3. All of the included studies were conducted in Africa – i.e. in East Africa,,,–,–,– West Africa,,,,, southern Africa or five countries scattered across Africa. Most were cross-sectional and none was a randomized control trial. Three of the studies were conducted in the 1990s and used the older version of the test for circulatory cathodic antigen.,, The rest were conducted after 2000. All but two of the included studies involved the detection of S. mansoni. Two involved the detection of S. haematobium (Fig. 2) and none investigated S. japonicum infections.
Fig. 2

Single point-of-care testing for circulatory cathodic antigen in the detection of Schistosoma haematobium infection: summary receiver-operating characteristic curve

Single point-of-care testing for circulatory cathodic antigen in the detection of Schistosoma haematobium infection: summary receiver-operating characteristic curve AUC: area under the curve. Notes: The analysed data came from two studies, in which, for each participant, filtration of a 10-ml urine sample served as the reference standard. Each participant was tested once for antigen, using reagent strips. In the antigen testing, all positive results – including trace positives – were considered indicative of infection. The graph contains six separate types of information, represented by six separate types of graphical feature. Hollow circles represent the point estimates for the sensitivity and specificity of each study. Each of these circles is surrounded by a light grey oval, which presents the 95% credible region associated with that particular study. Similarly, the summary models – produced by pooling the estimates from each of the studies using a standard bivariate model – are presented both as a point estimate, represented by a solid green circle, and an associated 95% credible region, represented by the black oval. In addition to this, the best estimate for how the sensitivity and specificity vary with the diagnostic threshold adopted is represented by a line which runs from the bottom left to the top right portion of the graph. The solid section of this line represents interpolated estimates – which fill in the gaps between the studies available – whereas the dashed parts of this line are extrapolated from the data and are therefore more dependent on the modelling assumptions. Both the interpolated and the extrapolated parts of this line are needed to estimate the AUC, which is a measure of the antigen test’s diagnostic accuracy. Each of two publications, reported studies conducted in settings of low, moderate and high endemicity. We treated each of these publications as a report on three studies, which we designated studies 1, 2 and 3. As another investigation had both adult and child participants and reported data separately for these two age groups, we were able to analyse its data as if they came from two studies. Since one publication included some data from primary research represented by other articles included in our analysis, we had to be careful to avoid duplicate analyses. When contacted, the authors of three included articles,, provided useful unpublished data.

One antigen test per participant

Versus single Kato–Katz

The accuracy of single antigen testing compared with single Kato–Katz reference testing – i.e. the examination of two smears of a single stool sample per participant – for the detection of S. mansoni infection had been investigated in seven studies,,,,,,, in Cameroon, Côte d’Ivoire, Ethiopia, Kenya and Uganda. Our meta-analysis of the data from these studies indicated that the antigen test had a high pooled sensitivity (0.90; 95% CI: 0.84–0.94) but a low pooled specificity (0.56; 95% CI: 0.39–0.71; Fig. 3). The area under the corresponding receiver-operating characteristic curve indicated that the antigen test had an accuracy of 0.86 (Fig. 4; available at: http://www.who.int/bulletin/volumes/94/7/15-158741). The same curve indicated that there had been wide variation in the antigen test’s false-positive rate when the test had been used to detect S. mansoni infection.
Fig. 3

Accuracy of single point-of-care testing for circulatory cathodic antigen in the detection of Schistosoma mansoni infection

Fig. 4

Single point-of-care testing for circulatory cathodic antigen in the detection of Schistosoma mansoni infection: summary receiver-operating characteristic curve

Accuracy of single point-of-care testing for circulatory cathodic antigen in the detection of Schistosoma mansoni infection FN: false negatives; FP: false positives; TN: true negatives; TP: true positives. Notes: The analysed data came from seven studies,,,,,, in which, for each participant, examination of duplicate Kato–Katz smears of a single stool sample served as the reference standard. In the antigen testing, all positive results – including trace positives – were considered indicative of infection. Data points for two studies, were extracted from a report that included primary data from a multi-country study in Africa. Although reagent strips were used as the antigen tests in two of the studies,, most of the data came from studies in which cassette assays had been used. Single point-of-care testing for circulatory cathodic antigen in the detection of Schistosoma mansoni infection: summary receiver-operating characteristic curve AUC: area under the curve. Notes: The analysed data came from seven studies,,,,,, in which, for each participant, examination of duplicate Kato–Katz smears of a single stool sample served as the reference standard. In the antigen testing, all positive results – including trace positives – were considered indicative of infection. Data points for two studies, were extracted from a report that included primary data from a multi-country study in Africa. Although reagent strips were used as the antigen tests in two of the studies,, most of the data came from studies in which cassette assays had been used. The graph contains six separate types of information, represented by six separate types of graphical feature. Hollow circles represent the point estimates for the sensitivity and specificity of each study. Each of these circles is surrounded by a light grey oval, which presents the 95% credible region associated with that particular study. Similarly, the summary models – produced by pooling the estimates from each of the studies using a standard bivariate model – are presented both as a point estimate, represented by a solid green circle, and an associated 95% credible region, represented by the black oval. In addition to this, the best estimate for how the sensitivity and specificity vary with the diagnostic threshold adopted is represented by a line which runs from the bottom left to the top right portion of the graph. The solid section of this line represents interpolated estimates – which fill in the gaps between the studies available – whereas the dashed parts of this line are extrapolated from the data and are therefore more dependent on the modelling assumptions. Both the interpolated and the extrapolated parts of this line are needed to estimate the AUC, which is a measure of the antigen test’s diagnostic accuracy.

Versus triple Kato–Katz

In 14 studies on the detection of S. mansoni infection – described in nine articles,,,,,,,, – single antigen testing had been compared with triple Kato–Katz reference testing – i.e. the examination of two smears of each of three consecutive stool samples per participant. When pooled, these comparisons indicated that the antigen test had a sensitivity of 0.85 (95% CI: 0.80–0.88) and a specificity of 0.66 (95% CI: 0.53–0.76). The wide CIs of some of the studies indicated the effects of small sample sizes. While the estimates of the antigen test’s sensitivity showed some consistency, there was huge variation in the corresponding estimates of specificity (Fig. 5).
Fig. 5

Accuracy of single point-of-care testing for circulatory cathodic antigen in the detection of Schistosoma mansoni infection

Accuracy of single point-of-care testing for circulatory cathodic antigen in the detection of Schistosoma mansoni infection FN: false negatives; FP: false positives; TN: true negatives; TP: true positives. Notes: The analysed data came from 14 studies,,,,,,,, in which, for each participant, examination of duplicate Kato–Katz smears of three or, in one study, two consecutive stool samples – in two studies,, combined with the results of formol–ether concentration – served as the reference standard. In the antigen testing, all positive results – including trace positives – were considered indicative of infection. Although reagent strips were used as the antigen tests in two of the studies,, most of the data came from studies in which cassette assays had been used. The data in one report that presented separate results for children aged 7–16 years and adults older than 16 years were treated as if they came from two independent studies.

Versus combined antigen test and Kato–Katz

One of the studies we included in our analysis had used the combined results of single antigen testing with single Kato–Katz reference testing in evaluating the performance of the antigen test when detecting S. mansoni infection. In this study, single antigen testing had been found to have a high sensitivity (90%) and optimal specificity (100%).

Three antigen tests per participant

In the study just described, the use of three antigen tests per participant led to slightly higher sensitivity (96%) and left specificity unchanged (100%). In eight of the studies we included in our analysis – i.e. three from Cameroon, four from Côte d’Ivoire, and one from Ethiopia – triple antigen testing for the detection of S. mansoni infection was compared with triple Kato–Katz reference testing. The meta-analysis of the data from these studies showed that triple antigen testing gave a pooled sensitivity of 0.91 (95% CI: 0.84–0.95) and a pooled specificity of 0.56 (95% CI: 0.39–0.72) (Fig. 6). Although the sensitivities of the triple antigen testing appeared to be fairly consistent across the studies, the corresponding specificities showed wide CIs and much between-study variability.
Fig. 6

Accuracy of double or triple point-of-care testing for circulatory cathodic antigen in the detection of Schistosoma mansoni infection

Accuracy of double or triple point-of-care testing for circulatory cathodic antigen in the detection of Schistosoma mansoni infection FN: false negatives; FP: false positives; TN: true negatives; TP: true positives. Notes: The analysed data came from eight studies,,, in which, for each participant, examination of duplicate Kato–Katz smears of three – or, in one study, two – consecutive stool samples served as the reference standard. Each participant was tested three times – or, in one study, twice – for antigen, using cassette assays. In the antigen testing, all positive results – including trace positives – were considered indicative of infection.

Latent class analysis

We analysed 32 data points from studies included in this review and identified two latent classes for the antigen testing (Table 2).
Table 2

Latent class analysis of the studies on the accuracy of point-of-care testing for circulatory cathodic antigen in the detection of schistosome infection included in the meta-analysis

Latent class and studyCCA test investigated, and no. of samples per participantNo. of stool samples per participanta
Latent class 1
Coulibaly, 2011Cassette (1)1
Coulibaly, 2011 (study 1)Cassette (1)3
Coulibaly, 2011 (study 1)Cassette (3)3
Coulibaly, 2011 (study 2)Cassette (1)3
Coulibaly, 2011 (study 2)Cassette (3)3
Coulibaly, 2011 (study 3)Cassette (1)3
Koukounari, 2013 (study 2)Cassette (1)3
Latent class 2
Legesse, 2007Cassette (1)1b
Legesse, 2008Reagent strip (1)1b
Standley, 2010Cassette (1)1
Shane, 2011Cassette (1)1
Coulibaly, 2011 (study 3)Cassette (3)3
Tchuem Tchuenté, 2012Cassette (1)1
Tchuem Tchuenté, 2012 (study 1)Cassette (1)3
Tchuem Tchuenté, 2012 (study 1)Cassette (3)3
Tchuem Tchuenté, 2012 (study 2)Cassette (1)3
Tchuem Tchuenté, 2012 (study 2)Cassette (3)3
Tchuem Tchuenté, 2012 (study 3)Cassette (1)3
Tchuem Tchuenté, 2012 (study 3)Cassette (3)3
Coulibaly, 2013Cassette (1)3
Coulibaly, 2013Cassette (2)2
Dawson, 2013Cassette (1)2
Erko, 2013Cassette (1)1
Erko, 2013Cassette (1)3
Erko, 2013Cassette (3)3
Koukounari, 2013 (study 1)Cassette (1)3
Sousa-Figueiredo, 2013Cassette (1)1
Sousa-Figueiredo, 2013 (study 1)Cassette (1)1
Sousa-Figueiredo, 2013 (study 2)Cassette (1)1
Sousa-Figueiredo, 2013 (study 3)Cassette (1)1
Adriko, 2014Cassette (1)1
Adriko, 2014Cassette (1)3

CCA: circulatory cathodic antigen.

a Each examined as a duplicate Kato–Katz smear.

b Stool samples were also checked by formol–ether concentration.

CCA: circulatory cathodic antigen. a Each examined as a duplicate Kato–Katz smear. b Stool samples were also checked by formol–ether concentration.

Discussion

In this review, we were disappointed by the lack of a relevant randomized controlled trial. Most of the data we analysed came from cross-sectional studies. Despite the variability in the design of the studies we investigated, including variation in the format of the antigen tests employed, the studies gave fairly consistent results. An independent study found no batch-to-batch variation in the cassette version of the antigen test we investigated, negligible intra-reader variability (2%) and substantial agreement in the inter-reader reliability of the test. As all the studies we included in our analysis were conducted in Africa and most only assessed the performance of antigen testing for detecting S. mansoni infection, there needs to be much caution in generalizing our findings to other endemic areas and other schistosome species. Additional studies – on the detection of S. mansoni beyond Africa and on the detection of other schistosome species throughout the tropics and subtropics – are encouraged. The finding that the antigen test performed better when endemicity was high than when it was low has both practice and control implications. As schistosome control becomes more successful, antigen testing may have no advantage over Kato–Katz smears or urine filtration. As there is no test for schistosome infection that has 100% sensitivity and 100% specificity, the apparent performance of any index test is partially dependent on the performance and other characteristics of the reference test or tests. Microscopy performed on multiple stool or urine samples – as appropriate – might be considered to be an effective parasitological gold standard. Researchers have suggested that a useful gold standard might be created by combining the results of the index and reference tests. However, the combined results of antigen and Kato–Katz testing might be adversely affected by false-positive antigen tests, false-negative Kato–Katz tests and interdependence in the two sets of results. When investigating the performance of antigen testing, it may be better to use a test with a low false-positive rate as the reference for sensitivity – e.g. Kato–Katz testing of multiple stool samples collected on different days from each participant – and to evaluate the test’s specificity using participants from non-endemic areas. An alternative approach would be to use a predicted gold standard at population level – like the pocket chart described by researchers. Although the combined results of antigen and Kato–Katz testing are not being employed in any current control programme, they may become a diagnostic option in the future. The absence of a clear and accurate reference standard creates additional uncertainty in the meta-analysis of results data from any diagnostic test. After investigating heterogeneity patterns through latent class bivariate analysis, we identified two latent classes (Table 2). As the substantial variation we observed in the diagnostic accuracy of the antigen test could not be entirely explained by a threshold effect, we conducted subgroup analyses. The results indicated that the number of urine samples tested per participant had little effect on the antigen test’s sensitivity and specificity (data available from corresponding author). When we attempted to relate latent class to several background factors, we found that the number of urine samples tested per participant and the study year and country had little effect on the antigen test’s accuracy (data available from corresponding author). Several other factors that could not be thoroughly explored at this stage – e.g. age, endemicity and effect of treatment – require further investigation. If not fully cured, most individuals covered by mass administrations of praziquantel will have light infections that can easily be missed by insensitive tests. Although we made no comparison of the antigen test’s performance before and after treatment, we evaluated the effect of endemicity on the performance of antigen testing with the specific aim of determining how the test would perform in settings with generally low intensities of infection. We appreciate the fact that important additional evidence could have come from post-treatment studies and – given that our meta-analysis involved mostly cross-sectional studies – there may have been unknown confounding factors. We are also aware that our analysis was limited to data from Africa recorded in 20 articles. Despite these limitations, the findings of the studies included in our analysis seem fairly consistent. Although the quality of the included studies was not formally assessed, potential sources of heterogeneity were explored. Our main conclusions are consistent with the available evidence shown and are likely to be reliable. In conclusion, the antigen testing we evaluated appears to represent an effective, easy and low-cost tool for mapping and monitoring programmes for the control of S. mansoni and, possibly, S. haematobium. Well-designed studies involving head-to-head comparisons of the cost and cost–effectiveness of antigen testing and either Kato–Katz smears or urine filtration and evaluations of the performance of antigen testing post-treatment are recommended.
  47 in total

1.  Immunodiagnosis of schistosomiasis by determination of the circulating antigens CAA and CCA, in particular in individuals with recent or light infections.

Authors:  L van Lieshout; A M Polderman; A M Deelder
Journal:  Acta Trop       Date:  2000-10-23       Impact factor: 3.112

2.  Response to: accuracy of circulating cathodic antigen tests for rapid mapping of Schistosoma mansoni and S. haematobium infections in Southern Sudan by RA Ashton et al. (2011) Trop Med Int Health 16, pp. 1099-1103.

Authors:  A M Deelder; G J van Dam; L van Lieshout
Journal:  Trop Med Int Health       Date:  2011-11-29       Impact factor: 2.622

3.  Assessment of cure by detection of circulating antigens in serum and urine, following schistosomiasis mass treatment in two villages of the Office du Niger, Mali.

Authors:  D De Clercq; M Sacko; J Vercruysse; V vanden Bussche; A Landouré; A Diarra; B Gryseels; A Deelder
Journal:  Acta Trop       Date:  1997-12       Impact factor: 3.112

Review 4.  Meta-Analysis. Potentials and promise.

Authors:  M Egger; G D Smith
Journal:  BMJ       Date:  1997-11-22

5.  Circulating anodic and cathodic antigen in serum and urine from Schistosoma haematobium-infected Cameroonian children receiving praziquantel: a longitudinal study.

Authors:  P G Kremsner; P Enyong; F W Krijger; N De Jonge; G M Zotter; F Thalhammer; F Mühlschlegel; U Bienzle; H Feldmeier; A M Deelder
Journal:  Clin Infect Dis       Date:  1994-03       Impact factor: 9.079

6.  Field-based evaluation of a reagent strip test for diagnosis of schistosomiasis mansoni by detecting circulating cathodic antigen (CCA) in urine in low endemic area in Ethiopia.

Authors:  M Legesse; B Erko
Journal:  Parasite       Date:  2008-06       Impact factor: 3.000

Review 7.  The unacknowledged impact of chronic schistosomiasis.

Authors:  Charles H King; Madeline Dangerfield-Cha
Journal:  Chronic Illn       Date:  2008-03

8.  Intestinal schistosomiasis in pre school-aged children of Lake Albert, Uganda: diagnostic accuracy of a rapid test for detection of anti-schistosome antibodies.

Authors:  Emily M Dawson; José C Sousa-Figueiredo; Narcis B Kabatereine; Michael J Doenhoff; J Russell Stothard
Journal:  Trans R Soc Trop Med Hyg       Date:  2013-08-24       Impact factor: 2.184

9.  Additional Evaluation of the Point-of-Contact Circulating Cathodic Antigen Assay for Schistosoma mansoni Infection.

Authors:  Pauline N M Mwinzi; Nupur Kittur; Elizabeth Ochola; Philip J Cooper; Carl H Campbell; Charles H King; Daniel G Colley
Journal:  Front Public Health       Date:  2015-03-19

10.  Evaluation of circulating cathodic antigen (CCA) urine-tests for diagnosis of Schistosoma mansoni infection in Cameroon.

Authors:  Louis-Albert Tchuem Tchuenté; Césaire Joris Kueté Fouodo; Romuald Isaka Kamwa Ngassam; Laurentine Sumo; Calvine Dongmo Noumedem; Christian Mérimé Kenfack; Nestor Feussom Gipwe; Esther Dankoni Nana; J Russell Stothard; David Rollinson
Journal:  PLoS Negl Trop Dis       Date:  2012-07-31
View more
  18 in total

1.  Rapid clearance of Schistosoma mansoni circulating cathodic antigen after treatment shown by urine strip tests in a Ugandan fishing community - Relevance for monitoring treatment efficacy and re-infection.

Authors:  Anna O Kildemoes; Birgitte J Vennervald; Edridah M Tukahebwa; Narcis B Kabatereine; Pascal Magnussen; Claudia J de Dood; André M Deelder; Shona Wilson; Govert J van Dam
Journal:  PLoS Negl Trop Dis       Date:  2017-11-13

2.  Understanding the relationship between egg- and antigen-based diagnostics of Schistosoma mansoni infection pre- and post-treatment in Uganda.

Authors:  Joaquín M Prada; Panayiota Touloupou; Moses Adriko; Edridah M Tukahebwa; Poppy H L Lamberton; T Déirdre Hollingsworth
Journal:  Parasit Vectors       Date:  2018-01-08       Impact factor: 3.876

3.  Field evaluation of a schistosome circulating cathodic antigen rapid test kit at point-of-care for mapping of schistosomiasis endemic districts in The Gambia.

Authors:  Bakary Sanneh; Ebrima Joof; Abdoulie M Sanyang; Kristen Renneker; Yaya Camara; Alhagie Papa Sey; Sheriffo Jagne; Ignatius Baldeh; Serign Jawo Ceesay; Sana M Sambou; Kisito Ogoussan
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

4.  Is POC-CCA a truly reliable test for schistosomiasis diagnosis in low endemic areas? The trace results controversy.

Authors:  José M Peralta; Marta G Cavalcanti
Journal:  PLoS Negl Trop Dis       Date:  2018-11-08

5.  Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review.

Authors:  Eric N Agbata; Rachael L Morton; Zeno Bisoffi; Emmanuel Bottieau; Christina Greenaway; Beverley-A Biggs; Nadia Montero; Anh Tran; Nick Rowbotham; Ingrid Arevalo-Rodriguez; Daniel T Myran; Teymur Noori; Pablo Alonso-Coello; Kevin Pottie; Ana Requena-Méndez
Journal:  Int J Environ Res Public Health       Date:  2018-12-20       Impact factor: 3.390

6.  Diagnostic Performance of Kato Katz Technique and Point-of-Care Circulating Cathodic Antigen Rapid Test in Diagnosing Schistosoma mansoni Infection in HIV-1 Co-Infected Adults on the Shoreline of Lake Victoria, Tanzania.

Authors:  Humphrey D Mazigo; Jorg Heukelbach
Journal:  Trop Med Infect Dis       Date:  2018-05-29

7.  Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi.

Authors:  Michelle N Clements; Paul L A M Corstjens; Sue Binder; Carl H Campbell; Claudia J de Dood; Alan Fenwick; Wendy Harrison; Donatien Kayugi; Charles H King; Dieuwke Kornelis; Onesime Ndayishimiye; Giuseppina Ortu; Mariama Sani Lamine; Antonio Zivieri; Daniel G Colley; Govert J van Dam
Journal:  Parasit Vectors       Date:  2018-02-23       Impact factor: 3.876

8.  Refining Diagnosis of Schistosoma haematobium Infections: Antigen and Antibody Detection in Urine.

Authors:  Claudia J de Dood; Pytsje T Hoekstra; Julius Mngara; Samuel E Kalluvya; Govert J van Dam; Jennifer A Downs; Paul L A M Corstjens
Journal:  Front Immunol       Date:  2018-11-14       Impact factor: 7.561

9.  Schistosoma mansoni infection and socio-behavioural predictors of HIV risk: a cross-sectional study in women from Uganda.

Authors:  Sergey Yegorov; Ronald M Galiwango; Sara V Good; Juliet Mpendo; Egbert Tannich; Andrea K Boggild; Noah Kiwanuka; Bernard S Bagaya; Rupert Kaul
Journal:  BMC Infect Dis       Date:  2018-11-19       Impact factor: 3.090

10.  Young Adults in Endemic Areas: An Untreated Group in Need of School-Based Preventive Chemotherapy for Schistosomiasis Control and Elimination.

Authors:  Harrison K Korir; Diana K Riner; Emmy Kavere; Amos Omondi; Jasmine Landry; Nupur Kittur; Eric M Ndombi; Bartholomew N Ondigo; W Evan Secor; Diana M S Karanja; Daniel G Colley
Journal:  Trop Med Infect Dis       Date:  2018-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.